Three-Year Outcomes With the Absorb Bioresorbable Scaffold | Zendy

Ziad A. Ali | Zendy; Runlin Gao | Zendy; Takeshi Kimura | Zendy; Yoshinobu Onuma | Zendy; Dean J. Kereiakes | Zendy; Stephen G. Ellis | Zendy; Bernard Chevalier | Zendy; Minh-Thien Vu | Zendy; Zhen Zhang | Zendy; Charles A. Simonton | Zendy; Patrick W. Serruys | Zendy; Gregg W. Stone | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Three-Year Outcomes With the Absorb Bioresorbable Scaffold

Author(s) -

Ziad A. Ali,

Runlin Gao,

Takeshi Kimura,

Yoshinobu Onuma,

Dean J. Kereiakes,

Stephen G. Ellis,

Bernard Chevalier,

Minh-Thien Vu,

Zhen Zhang,

Charles A. Simonton,

Patrick W. Serruys,

Gregg W. Stone

Publication year - 2017

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.117.031843

Subject(s) - medicine , everolimus , target lesion , myocardial infarction , cardiology , coronary artery disease , lesion , revascularization , confidence interval , thrombosis , relative risk , surgery , percutaneous coronary intervention

The Absorb bioresorbable vascular scaffold (BVS) completely resorbs within 3 years after coronary artery implantation. The safety and effectiveness of BVS through this critical 3-year period have not been characterized.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research